Dr. Tülay Yarkın
Pulmonology & Thoracic SurgeryVerified
- 28+years exp.
English · Turkish
FromPrice on request
Free quote
60 seconds · no obligationView Profile
Lung Transplant
Lung transplantation
What lung transplantation involves, when end-stage pulmonary failure requires single or double organ replacement, how donor matching and surgical anastomoses work, approximate costs in Turkey compared with the UK, US and Germany, candidate eligibility criteria, recovery milestones from intensive care to outpatient rehabilitation, clinical risks, and how to evaluate accredited thoracic transplant centres.
A written plan with the surgeon's name and the full price — usually within 24 hours.
- Category
- Lung Transplant
- Hospitals
- 2
- Verified
- 1
- Price from
- Price on request
Verified surgeons for Lung Transplantation
1 doctor Compare doctors, ratings and prices — ask any of them for a free quote.
Lung transplantation in Turkey: what it is and how it works
Lung transplantation is a major cardiothoracic operation in which diseased, failing lungs are replaced with healthy donor lungs. It is a definitive treatment for patients with end-stage respiratory failure who have exhausted medical therapies and supplemental oxygen. During the procedure, diseased lung tissue is removed and the donor organ is implanted by connecting the main bronchus for airway ventilation, the pulmonary artery for blood inflow, and a left atrial cuff to return oxygenated blood to the heart. When bilateral replacement is required, both lungs are replaced sequentially, often supported by extracorporeal membrane oxygenation (ECMO) to maintain circulation and gas exchange.
A lung transplant is not an elective procedure; it replaces end-stage respiratory disease with a manageable condition requiring lifelong immunosuppression and medical vigilance. International patients considering lung transplantation in Turkey must navigate regulatory requirements, multidisciplinary evaluation, and dedicated post-operative care. For an overview of respiratory surgery options, explore our guide to pulmonology treatments in Turkey.
How is lung transplantation performed step by step?
The operation requires a dedicated cardiothoracic team, invasive monitoring, and general anaesthesia. Depending on whether a single or double lung transplant is planned, surgery lasts six to twelve hours across several stages:
- Anaesthesia and circulatory support: General anaesthesia is administered with double-lumen intubation. Veno-arterial ECMO or cardiopulmonary bypass is established to maintain oxygenation and blood pressure during surgery.
- Surgical incision: A single transplant uses an anterolateral or posterolateral thoracotomy. Bilateral transplantation typically uses a transverse clamshell incision across the sternum to access both chest cavities.
- Pneumonectomy of the diseased lung: The failing lung is freed, and the pulmonary artery, veins, and main bronchus are divided, clearing the chest for the donor graft.
- Donor graft preparation: The donor organ is inspected, trimmed, and prepared on a sterile chilled table, matching bronchial and vascular cuffs to recipient anatomy.
- Vascular and airway anastomosis: The donor lung is positioned in the chest. Surgeons complete three connections: the main bronchus, the pulmonary artery, and the atrial cuff containing the pulmonary veins.
- Reperfusion and chest closure: Clamps are released to allow gradual reperfusion and reventilation. Chest drains are placed, and incisions are closed in layers.
Does lung transplantation work? Evidence and long-term survival
When asking does lung transplantation work, clinical success is measured by symptom relief and long-term survival. Registry data from the International Society for Heart and Lung Transplantation (ISHLT) confirm that transplantation reliably resolves severe breathlessness, eliminates supplemental oxygen dependence, and restores everyday physical independence in most surviving recipients.
Registry data show an overall median survival of approximately six to seven years across international centres. Survival varies by diagnosis, age, and procedure type. Younger patients receiving double lung transplants for cystic fibrosis often achieve median survival exceeding ten years, whereas patients with acute pulmonary fibrosis or pulmonary arterial hypertension face higher perioperative mortality during the initial three months.
Long-term survival is limited by organ rejection and infection. While modern immunosuppression prevents early acute rejection in most cases, chronic lung allograft dysfunction (CLAD) remains the main barrier to survival beyond five years. Transplantation is therefore an effective life-extending treatment requiring lifelong medical follow-up.
Lung transplantation cost in Turkey compared with the UK, US and Germany
Transplant expenditure reflects long operating hours, mechanical circulatory support, intensive care hospitalisation, and ongoing diagnostic testing. The table below outlines approximate cost ranges across major destinations. These figures represent general international estimates rather than individual hospital quotes.
| Country | Approximate cost range |
|---|---|
| Turkey | €65,000 – €140,000 |
| United Kingdom | €120,000 – €260,000 |
| United States | €450,000 – €1,200,000 |
| Germany | €140,000 – €320,000 |
Clinical variables affect the final lung transplantation cost. Factors include whether the procedure is single or double, duration of pre-operative ECMO bridging, days spent in intensive care, and post-operative dialysis needs. In Turkey, international packages typically cover recipient and donor testing, surgery, anaesthesia, ICU stay, ward accommodation, initial immunosuppressants, bronchoscopies, and airport transfers. Patients should confirm all inclusions in writing and request an itemised proposal through our free quote service before travelling.
Single vs double lung transplant: comparing surgical approaches
Transplant teams evaluate whether a patient requires a single or double lung transplant based on underlying disease, age, and cardiovascular health. In isolated structural disease confined to one lung, tissue removal without transplant may be considered; read our guide to pneumonectomy for unilateral conditions.
| Procedure or technique | Best suited to | Typical limits |
|---|---|---|
| Bilateral (double) lung transplant | Cystic fibrosis, bronchiectasis, severe pulmonary hypertension, younger candidates | Longer surgery; higher early physiological stress; requires two donor lungs |
| Single lung transplant | Idiopathic pulmonary fibrosis and selected older patients with emphysema | Unsuitable for chronic suppurative lung disease; native lung may develop complications |
| Living-donor lobar lung transplant | Critically ill paediatric or small-stature adults with two healthy family donors | Requires two compatible living donors; technically demanding vascular matching |
In chronic infectious diseases like cystic fibrosis, double lung transplantation is mandatory. Leaving a diseased native lung in place alongside an immunosuppressed donor organ causes fatal cross-infection. In contrast, a single lung transplant is suitable for pulmonary fibrosis, allowing one deceased donor to help two recipients.
Who is a candidate for a lung transplant, and who is not?
Candidacy requires extensive evaluation across pulmonary, cardiac, renal, and psychological specialties. Guidelines from the International Society for Heart and Lung Transplantation (ISHLT) define standard selection criteria:
- Qualifying indications: End-stage COPD with severe hypercapnia; progressive idiopathic pulmonary fibrosis with falling lung volumes; cystic fibrosis with frequent severe exacerbations; and advanced pulmonary arterial hypertension unresponsive to maximum medical therapy.
- Clinical window: Candidates typically have a projected two-year survival below 50% without surgery, but retain sufficient physical strength and nutritional reserve to endure surgery and intensive rehabilitation.
- Absolute contraindications: Active malignancy within the past two to five years; severe dysfunction of other vital organs like the liver or kidneys; untreatable chronic infections; severe chest wall deformities; and progressive systemic disease.
- Lifestyle criteria: Active smoking or nicotine use within the preceding six months is an absolute barrier. Candidates must demonstrate reliable medical adherence and have a dedicated family caregiver.
Donor matching and legal frameworks for international patients in Turkey
Organ transplantation in Turkey operates under strict statutory oversight directed by the Turkish Ministry of Health. Patients evaluating lung transplantation Turkey options must understand the legal parameters governing international care.
Deceased donor organs in Turkey are allocated by law to Turkish citizens on national waiting lists. Therefore, foreign nationals pursuing transplantation in Turkey typically require living-donor lobar lung transplantation (LDLLT). In this procedure, two biologically related family members (up to fourth-degree relatives) each donate a lower lobe to replace the recipient's lungs. All living-donor arrangements must pass formal review by an ethics committee and judicial authorities to verify voluntary consent, genuine kinship, and complete absence of commercial transaction.
Biological matching is rigorous. Requirements include ABO blood type compatibility, HLA cross-matching to prevent antibody-mediated hyperacute rejection, and volumetric chest CT scans to confirm donor lobes match recipient thoracic dimensions precisely. Size mismatches can cause graft compression or chronic pleural complications.
Life after lung transplantation: what to expect before and after surgery
Preparing for life before and after lung transplantation helps patients maintain realistic expectations. Before surgery, patients face disabling breathlessness, continuous oxygen dependency, and severe physical exhaustion during minimal exertion.
After successful surgery and rehabilitation, the functional improvement is significant. Recipients breathe without supplemental oxygen, walk independently, and rebuild physical stamina. Within six to twelve months, many return to desk work, driving, and routine domestic life.
However, life with a transplant requires permanent discipline. Patients must take immunosuppressive medications every twelve hours without fail. Daily home spirometry, blood pressure tracking, and strict infection precautions (avoiding sick contacts and crowded indoor environments) are mandatory. Routine clinic appointments, blood tests, and surveillance bronchoscopies remain necessary indefinitely to detect early rejection.
Hospital stay, pulmonary rehabilitation and lung transplantation recovery
The lung transplantation recovery pathway requires close collaboration between the surgical team, respiratory physiotherapists, and family caregivers:
- Intensive Care Unit (Days 1 to 7): Patients are monitored in a cardiothoracic ICU. Ventilator weaning occurs within 24 to 72 hours if graft function is stable. Chest drains, blood gases, and arterial lines are monitored continuously.
- Inpatient Ward (Weeks 2 to 4): Patients transfer to the thoracic ward to begin aggressive chest physiotherapy, walking exercises, nutritional support, and medication management training.
- Outpatient Stay in Turkey (Weeks 5 to 12): International patients remain near the hospital for two to three months after discharge. Bi-weekly visits monitor lung function, immunosuppressant drug levels, chest imaging, and transbronchial biopsies.
- Fit-to-Fly Clearance: Travel clearance is granted only when incisions have healed, drug levels are therapeutic, and lung function is stable without rejection or active infection. Review travel planning details in our guide explaining how it works.
Risks and complications of lung transplantation
Lung transplantation carries substantial clinical risks because the lungs interact directly with the external environment. Recognized complications reported by the NHS, ISHLT, and the British Thoracic Society include:
- Primary graft dysfunction: Severe acute lung injury in the first 72 hours after reperfusion, causing hypoxaemia and lung infiltrates. It occurs in 10% to 20% of patients and may require temporary ECMO support.
- Rejection: Acute cellular or antibody-mediated rejection occurs when the immune system attacks donor tissue. Most patients experience at least one episode during the first year, treated with high-dose corticosteroids.
- Infection: Immunosuppressive therapy increases vulnerability to bacterial pneumonia, cytomegalovirus (CMV), and fungal infections such as Aspergillus. Preventive antimicrobial medications are prescribed for months.
- Airway complications: Reduced blood supply to the donor bronchial connection can cause narrowing (stenosis) or breakdown (dehiscence), requiring balloon dilation or stenting.
- Medication toxicity: Immunosuppressive drugs like tacrolimus can cause kidney strain, high blood pressure, diabetes, and tremors.
- Chronic lung allograft dysfunction (CLAD): Long-term scarring of small airways (bronchiolitis obliterans) causes gradual decline in lung capacity and remains the primary challenge after five years.
Choosing an accredited thoracic transplant centre in Turkey and questions to ask
Choosing a transplant facility demands thorough verification. International patients must confirm that the hospital is a licensed organ transplantation centre accredited by the Turkish Ministry of Health. The centre must provide 24-hour cardiothoracic ICU cover, ECMO capability, on-site histopathology, and comprehensive tissue typing. Learn more about specialised pulmonology treatments in Turkey.
Red flags include intermediaries promising quick donor allocation, operating without formal ethical committee oversight, or quoting fixed non-medical packages without reviewing detailed clinical records. Ask the surgical team these essential questions:
- Is your transplant centre officially licensed by the Turkish Ministry of Health for thoracic organ transplantation?
- How many lung transplant procedures does your surgical team perform each year?
- What are the centre's one-year and three-year patient and graft survival rates?
- Is 24-hour ECMO and cardiothoracic intensive care available on site?
- What legal documentation and ethics committee approvals are required for living-donor evaluation?
- What surveillance bronchoscopy and drug monitoring schedule is followed after discharge?
- How will your team communicate and coordinate long-term care with my local pulmonologist after I return home?
To evaluate your candidacy with qualified thoracic transplant teams, submit your medical history for review through our free quote portal.
Hospitals with Pulmonology & Thoracic Surgery in Turkey
Frequently asked questions
Lung transplantation is a major surgical procedure in which diseased, non-functioning lungs are replaced with healthy donor lungs. It is performed for end-stage respiratory failure caused by conditions such as chronic obstructive pulmonary disease, pulmonary fibrosis, or cystic fibrosis when all medical therapies and supplemental oxygen options have been exhausted.
Yes. Lung transplantation reliably restores oxygen independence, resolves severe resting breathlessness, and improves physical mobility. International registry data from the ISHLT report an overall median survival of six to seven years, with younger cystic fibrosis patients often exceeding ten years. Long-term outcomes depend on preventing infection and chronic rejection through lifelong immunosuppressive therapy.
Lung transplantation in Turkey typically costs between €65,000 and €140,000, compared with €120,000 to €260,000 in the UK and upwards of €450,000 in the US. Total cost depends on surgical complexity, single or double graft selection, ICU duration, and pre-operative mechanical support. Comprehensive packages generally cover hospitalisation, surgery, anaesthesia, and initial post-operative rehabilitation.
Before surgery, patients experience severe dyspnoea, reduced mobility, and constant dependency on supplemental oxygen. Following successful transplantation and rehabilitation, recipients breathe freely without external oxygen, walk independently, and resume daily personal and social activities. However, patients must adapt to lifelong immunosuppressive medications, routine clinical monitoring, and strict daily infection prevention measures.
A single lung transplant replaces one lung, which is suitable for conditions like idiopathic pulmonary fibrosis in older adults. A double lung transplant replaces both lungs and is mandatory for suppurative lung diseases like cystic fibrosis or extensive bronchiectasis, where leaving a native infected lung in place would cause fatal graft infection.
Immediate recovery involves one to two weeks in hospital, including several days in cardiothoracic intensive care. International patients remain in Turkey for two to three months of outpatient pulmonary rehabilitation, surveillance bronchoscopies, and drug monitoring. Full physical recovery and cardiovascular adaptation continue over six to twelve months under multidisciplinary supervision.
Because the surgery involves a thoracotomy or clamshell incision dividing chest wall muscles, post-operative discomfort can be substantial. Cardiothoracic teams manage pain proactively using thoracic epidurals, patient-controlled analgesia, regional nerve blocks, and oral medications. Effective pain relief is crucial to allow early deep breathing, coughing, and active respiratory physiotherapy.
The lifespan of a transplanted lung depends on recipient health, organ matching, and immune response. While median survival is approximately six to seven years globally, many recipients live ten to fifteen years or longer. Chronic lung allograft dysfunction (CLAD) and infections represent the primary factors limiting long-term graft survival.
Major risks include primary graft dysfunction in the initial 72 hours, acute cellular or antibody-mediated rejection, opportunistic viral or fungal infections, bronchial anastomosis narrowing, and chronic lung allograft dysfunction. Long-term immunosuppression can also cause kidney strain, high blood pressure, and diabetes, requiring ongoing therapeutic monitoring by transplant specialists.
International patients should plan for a total stay of roughly 10 to 14 weeks in Turkey. This timeline encompasses pre-operative donor and recipient compatibility evaluations, two to four weeks of inpatient surgical care, and six to ten weeks of close outpatient monitoring, surveillance bronchoscopies, and rehabilitation before receiving fit-to-fly clearance.
Patient stories